Table 3 Determination of oxidative and inflammatory markers within the cases.

From: Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients

Variable

Control (n = 498)

Patient (n = 498)

P Value

MDA nmol/ml

1.92 ± 0.059

3.77 ± 0.87

0.009

SOD µg/ml

0.54 ± 0.08

0.11 ± 0.01

0.013

GSH µg/ml

10.68 ± 1.23

4.42 ± 0.15

0.021

CAT nmol.mol

3.95 ± 0.11

2.13 ± 0.13

0.03

IL1 pg/ml

2.34 ± 0.53

6.97 ± 1.54

0.005

IL2 pg/ml

3.85 ± 0.64

7.84 ± 1.14

0.015

IL4 pg/ml

3.21 ± 0.70

7.44 ± 1.65

0.003

IL6 pg/ml

2.92 ± 0.69

8.81 ± 1.51

0.004

IL8 pg/ml

2.48 ± 0.56

6.09 ± 0.87

0.003

IL13 pg/ml

3.86 ± 0.74

7.45 ± 1.32

0.034

IL17 pg/ml

4.33 ± 0.95

8.71 ± 1.25

0.042

HSP27 pg/ml

4.41 ± 0.96

16.35 ± 1.37

0.003

HSP70 pg/ml

6.55 ± 1.38

22.81 ± 3.12

0.004

HSP90 pg/ml

6.05 ± 1.33

47.68 ± 4.87

0.003

TNFa pg/ml

13.13 ± 2.66

31.04 ± 8.64

0.012

NO ppm

5.95 ± 1.28

20.82 ± 4.08

0.019

iNOS ppm

5.45 ± 0.99

21.47 ± 8.76

0.005

MMP1 ng/ml

27.16 ± 4.50

55.83 ± 7.41

0.005

MMP2 ng/ml

37.50 ± 5.81

215.34 ± 16.49

0.039

MMP3 ng/ml

37.00 ± 6.06

204.81 ± 22.45

0.026

MMP7 ng/ml

45.26 ± 7.45

73.12 ± 8.73

0.031

MMP8 ng/ml

48.02 ± 8.15

76.71 ± 9.01

0.005

MMP9 ng/ml

42.00 ± 11.98

163.85 ± 22.38

0.015

Vitamin A IU

525.35 ± 81.92

406.23 ± 77.49

0.032

Vitamin C mg/dL

0.61 ± 0.01

0.36 ± 0.078

0.011

Vitamin D nmol/L

13.19 ± 0.91

9.46 ± 0.76

0.011